{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:54:08Z","timestamp":1794434048051,"version":"4.9.1"},"reference-count":75,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T00:00:00Z","timestamp":1405641600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:sec id=\"S0033291714001305_sec_a1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence synthesis methods enabling direct and indirect comparisons over the entire set of relevant clinical data produce quantitative point estimates for the treatments contrasts between competing interventions, and provide a hierarchical rank ordering between them. We aimed to provide evidence-based guidance on the efficacy and all-cause discontinuation of antimanic treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0033291714001305_sec_a2\" sec-type=\"methods\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We conducted a network meta-analysis within a Bayesian framework. We searched all standard literature databases without language restrictions up to 15 January 2014 to identify reports of short-term, randomized, blinded trials of putative antimanic drugs as monotherapy for adults with bipolar-I mania.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0033291714001305_sec_a3\" sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Altogether, 14256 manic patients randomized to one of 18 active treatments or placebo provided 95 direct comparisons on 128 data points. For the primary outcome, standardized mean difference as Hedges\u2019\n                      <jats:italic>g<\/jats:italic>\n                      (standardized mean difference; SMD), the hierarchies indicated by surface under the cumulative ranking (SUCRA) probabilities were in agreement with the point estimates for all antimanic drugs identified as effective. For the 12 effective antimanic drugs on clinical use, SMDs against placebo ranged from 0.32 to 0.66 without superiority of one over another, except for risperidone\n                      <jats:italic>v<\/jats:italic>\n                      . aripiprazole and valproate. Aripiprazole, olanzapine, quetiapine, risperidone, and valproate had less all-cause discontinuation rates than placebo. Sensitivity analysis by drug class indicated similar efficacy profiles for haloperidol, second-generation antipsychotics, and mood stabilizers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0033291714001305_sec_a4\" sec-type=\"conclusion\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hierarchical rank ordering by comparative efficacy and risk of all-cause discontinuations should help to guide antimanic treatment choices by clinicians, healthcare policy makers, and guideline developers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/s0033291714001305","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T09:47:42Z","timestamp":1405676862000},"page":"299-317","source":"Crossref","is-referenced-by-count":118,"title":["A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania"],"prefix":"10.1017","volume":"45","author":[{"given":"A.","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nikodem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Baldessarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2014,7,18]]},"reference":[{"key":"S0033291714001305_ref46","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04854yel"},{"key":"S0033291714001305_ref6","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"S0033291714001305_ref8","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-3710-9"},{"key":"S0033291714001305_ref50","first-page":"47","article-title":"Open randomized comparative twelve-week study of lithium and valproate in manic episode [in Russian]","volume":"109","author":"Mosolov","year":"2009","journal-title":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova"},{"key":"S0033291714001305_ref54","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.9.844"},{"key":"S0033291714001305_ref55","unstructured":"Pfizer Clinical Trial Results Database (2008). Multicenter, randomized, double-blind, parallel group study, comparing the efficacy and tolerability of ziprasidone (Zeldox, Geodon) vs olanzapine (Zyprexa) in the treatment and maintenance of response in patients with acute mania. Study ID Number: A1281147. ClinicalTrials.gov: NCT00329108 (data on file)."},{"key":"S0033291714001305_ref57","doi-asserted-by":"publisher","DOI":"10.1177\/0962280207080643"},{"key":"S0033291714001305_ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.11.011"},{"key":"S0033291714001305_ref48","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.5.543"},{"key":"S0033291714001305_ref74","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"S0033291714001305_ref51","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbu030"},{"key":"S0033291714001305_ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.11.014"},{"key":"S0033291714001305_ref37a","volume-title":"Bipolar Book: History, Neurobiology, and Treatment","author":"Kriston"},{"key":"S0033291714001305_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60046-5"},{"key":"S0033291714001305_ref28","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09060802"},{"key":"S0033291714001305_ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770310043002"},{"key":"S0033291714001305_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.10.013"},{"key":"S0033291714001305_ref3","unstructured":"Ades AE , Welton N , Lu G. Introduction to Mixed Treatment Comparisons. (https:\/\/www.bris.ac.uk\/cobm\/research\/mpes\/mtc.html). Accessed 20 January 2014."},{"key":"S0033291714001305_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60873-8"},{"key":"S0033291714001305_ref45","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn414"},{"key":"S0033291714001305_ref34","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.7.972"},{"key":"S0033291714001305_ref30","doi-asserted-by":"publisher","DOI":"10.3310\/hta9260"},{"key":"S0033291714001305_ref23","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3767"},{"key":"S0033291714001305_ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7521.897"},{"key":"S0033291714001305_ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(09)70736-9"},{"key":"S0033291714001305_ref32","volume-title":"Manic-Depressive Illness","author":"Goodwin","year":"2007"},{"key":"S0033291714001305_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2008.12.014"},{"key":"S0033291714001305_ref1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200624010-00001"},{"key":"S0033291714001305_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.12.049"},{"key":"S0033291714001305_ref49","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-9-2"},{"key":"S0033291714001305_ref40","first-page":"89","article-title":"Carbamazepine vs. lithium in mania: double-blind study","volume":"48","author":"Lerer","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0033291714001305_ref63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2007.01066.x"},{"key":"S0033291714001305_ref42","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X253933"},{"key":"S0033291714001305_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(13)70597-2"},{"key":"S0033291714001305_ref33","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713001168"},{"key":"S0033291714001305_ref19","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M"},{"key":"S0033291714001305_ref67","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713000278"},{"key":"S0033291714001305_ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7168.1309"},{"key":"S0033291714001305_ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"S0033291714001305_ref29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1176\/ajp.149.1.121","article-title":"Verapamil vs. lithium in acute mania","volume":"149","author":"Garza-Trevi\u00f1o","year":"1992","journal-title":"American Journal of Psychiatry"},{"key":"S0033291714001305_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(94)00074-J"},{"key":"S0033291714001305_ref53","first-page":"44","article-title":"Carbamazepine vs haloperidol in treatment of manic episodes: controlled clinical trial","volume":"16","author":"Ortega Soto","year":"1993","journal-title":"(Spanish) Salud Mental"},{"key":"S0033291714001305_ref11","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3282fd827c"},{"key":"S0033291714001305_ref69","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2007.43"},{"key":"S0033291714001305_ref35","unstructured":"Jonas D , Wilkins T , Bangdiwala S , Bann C , Morgan L , Thaler K , Amick H , Gartlehner G (2013). Findings of Bayesian Mixed Treatment Comparison Meta-Analyses, Comparison and Exploration using Real-World Trial data and Simulation. Agency for Healthcare Research and Quality (US), Methods Research Report No. 13-EHC039-EF."},{"key":"S0033291714001305_ref18","article-title":"Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London","volume":"6","author":"Chang","year":"2011","journal-title":"PLoS ONE"},{"key":"S0033291714001305_ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198907000-00005"},{"key":"S0033291714001305_ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.08.013"},{"key":"S0033291714001305_ref64","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000380"},{"key":"S0033291714001305_ref24","doi-asserted-by":"publisher","DOI":"10.1038\/386824a0"},{"key":"S0033291714001305_ref61","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9868.00353"},{"key":"S0033291714001305_ref73","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145710001641"},{"key":"S0033291714001305_ref71","article-title":"Critical issues on use of network meta-analysis in psychiatry","author":"Yildiz","journal-title":"Harvard Review of Psychiatry"},{"key":"S0033291714001305_ref70","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199300532.001.0001"},{"key":"S0033291714001305_ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.57"},{"key":"S0033291714001305_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.06.008"},{"key":"S0033291714001305_ref52","unstructured":"Novartis Clinical Trial Results Database (2007). Randomized, double-blind, placebo-controlled multicenter study to evaluate efficacy and tolerability of licabazepine 1000\u20132000\u00a0mg\/d in the treatment of manic episodes of bipolar I disorder over 3 weeks. Study ID Number: CLIC477D2301. ClinicalTrials.gov: NCT00099229 (data on file)."},{"key":"S0033291714001305_ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f3646"},{"key":"S0033291714001305_ref9","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.128.6.688"},{"key":"S0033291714001305_ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.10.001"},{"key":"S0033291714001305_ref31","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363190-00009"},{"key":"S0033291714001305_ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2257"},{"key":"S0033291714001305_ref68","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.042"},{"key":"S0033291714001305_ref62","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770300115013"},{"key":"S0033291714001305_ref12","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328333ac1b"},{"key":"S0033291714001305_ref43","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1875"},{"key":"S0033291714001305_ref44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00714.x"},{"key":"S0033291714001305_ref60","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31818ce5ba"},{"key":"S0033291714001305_ref7","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145708009802"},{"key":"S0033291714001305_ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2011.12.004"},{"key":"S0033291714001305_ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"S0033291714001305_ref72","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.192"},{"key":"S0033291714001305_ref27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/ajp.149.1.108","article-title":"Double-blind comparison of valproate and lithium in the treatment of acute mania","volume":"149","author":"Freeman","year":"1992","journal-title":"American Journal of Psychiatry"},{"key":"S0033291714001305_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(12)70432-7"},{"key":"S0033291714001305_ref75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00530.x"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291714001305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T16:13:54Z","timestamp":1555863234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291714001305\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,18]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0033291714001305"],"URL":"https:\/\/doi.org\/10.1017\/s0033291714001305","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,18]]}}}